Información del producto
- 6-(2-Chlorophenyl)-7,10-dihydro-N-(4-methoxyphenyl)-1-methyl-4H-pyrido[4′,3′:4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-9(8H)-carboxamide
- 4H-Pyrido[4′,3′:4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-9(8H)-carboxamide, 6-(2-chlorophenyl)-7,10-dihydro-N-(4-methoxyphenyl)-1-methyl-
- BN 50727
Setipafant is a prodrug that is reconstituted with solvents to form a diluent that can be used in the manufacture of medicines. It is a hydrophobic compound and can be used as a linker for drugs that are insoluble in water. Setipafant has been shown to lower blood pressure by reducing the peripheral vascular resistance and increasing cardiac output. This drug also inhibits nitric oxide release from vascular endothelial cells, which may contribute to its hypotensive effects. The anti-viral activity of setipafant has been demonstrated in vitro against HIV-1, HSV-2, influenza A virus and vesicular stomatitis virus (VSV).
Propiedades químicas
Consulta técnica sobre: 3D-HFA41835 Setipafant
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.